Ligand Pharmaceuticals Incorporated (LGND)
NASDAQ: LGND · Real-Time Price · USD
241.79
+10.52 (4.55%)
At close: Apr 27, 2026, 4:00 PM EDT
245.00
+3.21 (1.33%)
After-hours: Apr 27, 2026, 7:18 PM EDT
Ligand Pharmaceuticals Analyst Ratings
Total Analysts
7
Consensus Rating
Strong Buy
Price Target
$247.29
Upside
+2.27%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy Maintains $276 → $282 | Strong Buy | Maintains | $276 → $282 | +16.63% | Apr 15, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $239 → $243 | Strong Buy | Maintains | $239 → $243 | +0.50% | Apr 14, 2026 |
| Citigroup | Citigroup | Strong Buy Maintains $270 → $276 | Strong Buy | Maintains | $270 → $276 | +14.15% | Mar 24, 2026 |
| B of A Securities | B of A Securities | Strong Buy Initiates $244 | Strong Buy | Initiates | $244 | +0.91% | Mar 11, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $275 → $277 | Buy | Maintains | $275 → $277 | +14.56% | Feb 27, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $231 → $239 | Strong Buy | Maintains | $231 → $239 | -1.15% | Feb 24, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $234 → $235 | Buy | Maintains | $234 → $235 | -2.81% | Dec 10, 2025 |
| Stifel | Stifel | Strong Buy Maintains $220 → $230 | Strong Buy | Maintains | $220 → $230 | -4.88% | Dec 10, 2025 |
| Citigroup | Citigroup | Strong Buy Initiates $270 | Strong Buy | Initiates | $270 | +11.67% | Dec 9, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $185 → $234 | Buy | Maintains | $185 → $234 | -3.22% | Nov 10, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $250 → $275 | Buy | Maintains | $250 → $275 | +13.74% | Nov 7, 2025 |
| Benchmark | Benchmark | Strong Buy Maintains $175 → $220 | Strong Buy | Maintains | $175 → $220 | -9.01% | Nov 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $206 → $231 | Strong Buy | Maintains | $206 → $231 | -4.46% | Nov 6, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $190 → $250 | Buy | Maintains | $190 → $250 | +3.40% | Nov 3, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $167 → $190 | Buy | Maintains | $167 → $190 | -21.42% | Sep 3, 2025 |
| Benchmark | Benchmark | Strong Buy Maintains $160 → $175 | Strong Buy | Maintains | $160 → $175 | -27.62% | Sep 2, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.